1. Home
  2. ICMB vs PLUR Comparison

ICMB vs PLUR Comparison

Compare ICMB & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Investcorp Credit Management BDC Inc.

ICMB

Investcorp Credit Management BDC Inc.

HOLD

Current Price

$1.88

Market Cap

33.5M

Sector

Finance

ML Signal

HOLD

Logo Pluri Inc.

PLUR

Pluri Inc.

HOLD

Current Price

$3.05

Market Cap

33.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICMB
PLUR
Founded
2012
2001
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.5M
33.9M
IPO Year
2013
2001

Fundamental Metrics

Financial Performance
Metric
ICMB
PLUR
Price
$1.88
$3.05
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
55.9K
5.4K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
27.66%
N/A
EPS Growth
N/A
10.78
EPS
0.04
N/A
Revenue
N/A
$1,336,000.00
Revenue This Year
N/A
$97.38
Revenue Next Year
$4.75
$293.97
P/E Ratio
$47.00
N/A
Revenue Growth
N/A
309.82
52 Week Low
$1.60
$2.82
52 Week High
$3.28
$7.13

Technical Indicators

Market Signals
Indicator
ICMB
PLUR
Relative Strength Index (RSI) 27.26 48.34
Support Level N/A $3.19
Resistance Level $3.00 $3.42
Average True Range (ATR) 0.18 0.18
MACD -0.03 -0.01
Stochastic Oscillator 26.09 42.43

Price Performance

Historical Comparison
ICMB
PLUR

About ICMB Investcorp Credit Management BDC Inc.

Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: